Late-Onset, Cryptic and Classical 21-0H Deficiency: Allelic Variants HLA genotyping and hormonal studies in 9 females with non-classical steroid 21-hydroxylase deficiency (AAH) indicate that this disorder is due to an autosomal recessive gene l inked to HLA, simi l ar to classical and cryptic 21-hydroxylase deficiency (21-0H def) . They had normal genitalia at birth and presented between 9 mos to 16 yrs with varying degrees of virilization . Hormonal studies of the families revealed 2 fathers and their HLA identical sisters with 21-0H def. The remain ing parents and the sibs sharing one HLA haplotype with the AAH patient responded to ACTH stimulation as heterozygotes for classical or cryptic 21-0H def . Five sibs who were HLA i dent ical to their affected sib also had findings diagnostic of 21-0H def. The hormonal response to ACTH of the patients with AAH and their HLA identical sibs was similar to that of pat ients with cryptic 21-OH def . Thus, individuals with these non-classical forms of 21-0H def and similar hormonal f indings present with a cl inical spectrum ranging from an asymptomat ic deficiency to precocious pubic hair, acne, tall stature and advanced bone age, hirsutism, cl itoromegaly and menstrual irregularities. The results of these studies support the concept that AAH, similar to classical and cryptic 21-0H def is due to an HLA linked autosomal recessive gene and that these disorders are due to allelic variants at the locus of steroid 21-hydroxyl ase ,
Diagnosis and oootrol of treabtelt of ccngenital adrenal hypeq>la-s13 (C1III) by semiautanated capillary gas-liquid-dlranat.ograply (cG!.C) of steroid trillethylsilyl-enolethers ('DISEE).
C1III due to 21-hydrc»cylase (21-HIl), ll-hydrc»cylase (ll-HIl) or 3~ hydrc»cysteroiddehydrogenase (3B-1ISD) deficiency can be diagnosed by detection of specific urinary steroid netabolites.~, C1III-treabtelt can be oootrolled by quantitatial of specific netabolites i.e.pregnane-3a, 17a,20axiol and pregnane-3a, 17a,20otriol-ll 00 in 21-HIl, tetrah}'dro-ll-desaxycortisol in l1-HIl anjA5pregnene-3~,17a
20axiol anj 16Clh~pregnene-3~01-20 00 in 31)-1ISD. we have develq>ed a sensitive, highly specific autanated nethod for the quantitative cG!.C of 'DISEE of these anj other steroids. '!be nethod includes enzymatic hydrolysis, ether extractiaI, ooe-step derivatisatioo using N-1Iethyl-N-trillethylsilyl-trifluoracetamid in presence of sodium acetate. 'lbe autanated cG!.C using solid injectial separates about 10 sanples/night. Because of the high resolutial, 00 further purification step is needed. Mean coefficient of variatial of the entire nethod is 12%. l1rlI<Jn,m steroids can be detected by cG!.C anj identified by mass spectraretry. '!be 'DISEE are ooovenient and stable enough for cG!.C ex:t'ldi ti.ons. Ranges of steroid excretia1 in the different fonns of C1III for four different aqe grcups indicating optimal treabtelt have been established. In CCI'lClusial, cG!.C with steroid 'DISEE provides a precise, rapid and oc:nvenient tool for both diagnosis and treabtelt oootrol of C1III. We have devised nomograms relating the baseline and ACTH stimulable levels of 17-0HP,~4-androstenedione and testosterone for genotyping 21-hydroxylase deficiency . The nomograms provide a method for classifying the patient with congenita l , late onset or cryptic 21-hydroxylase deficiency a s well as classifying the heterozygotes for each of these disorders . In addition , the subject predicted by HLA genotyping to be genetically unaf fected can also be classified by these nomograms . Further the nomograms permit us to obtain evidence for genetic recombination between HLA and the 21-hydroxylase locus. For example a patient predicted by initial HLA genotyping to be unaffected was classified by the nomogram to be a heterozygote. When HLA-DR typing was performed an informative maternal HLA A:DR recombination was discovered . This r ecomb in a t ion explained the heterozygote response of this subject. In another family a maternal DR :GLO recombination was found in an asymptomatic sister who was HLA identical to the patient with late onset 21-hydroxylase deficiency. Although most recombinants have mapped the gene for 21-hydroxylase between B and DR , this DR :GLO recombination presents evidence that there may also be a 21-hydroxylase locus between the DR-GLO loci. The nomograms thus provide a powerful t ool to determine the 21-hydroxylase genotype by hormonal testing and assiat in mapping the gene for 21-hydroxylase de ficien c y. 
